Skip to main content
Premium Trial:

Request an Annual Quote

Qlucore Licenses Data Analysis Tool to SinoGenomax

NEW YORK (GenomeWeb News) – Swedish bioinformatics company Qlucore recently announced a licensing deal with genomics research firm SinoGenoMax for use of Qlucore's data analysis tool.

Qlucore's product, called Qlucore Omics Explorer, allows researchers to study their data for patterns and structures, eliminating the need for statistics or computer experts to use the product effectively, it said.

Qlucore Omics Explorer uses dynamic principal component analysis, which projects high dimensional data "down to lower dimensions," the company said. The specific projections of the data are chosen "in order to maintain as much variance as possible in the projected dataset. With Qlucore Omics Explorer, data is projected and plotted on the two-dimensional computer screen and then rotated manually or automatically."

Based in Beijing, SinoGenoMax was a participant in the International Human Genome Sequencing Project, and was involved in genome-related projects including the sequencing of pathogenic microorganisms and the sequencing of Chinese population single nucleotide polymorphisms.

Financial and other terms of the deal were not disclosed.

The Scan

Support for Moderna Booster

An FDA advisory committee supports authorizing a booster for Moderna's SARS-CoV-2 vaccine, CNN reports.

Testing at UK Lab Suspended

SARS-CoV-2 testing at a UK lab has been suspended following a number of false negative results.

J&J CSO to Step Down

The Wall Street Journal reports that Paul Stoffels will be stepping down as chief scientific officer at Johnson & Johnson by the end of the year.

Science Papers Present Proteo-Genomic Map of Human Health, Brain Tumor Target, Tool to Infer CNVs

In Science this week: gene-protein-disease map, epigenomic and transcriptomic approach highlights potential therapeutic target for gliomas, and more